Rigel Pharma (RIGL) Tops Q2 EPS by 2c, Revenues Beat

August 6, 2019 5:40 PM

Rigel Pharma (NASDAQ: RIGL) reported Q2 EPS of ($0.12), $0.02 better than the analyst estimate of ($0.14). Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found